41. Bleomycin concentration in patientsʹ plasma and tumors after electrochemotherapyAleš Grošelj, Maša Bošnjak, Mojca Kržan, Tina Kosjek, Krisztina Bottyán, Helena Plešnik, Črt Jamšek, Maja Čemažar, Erika Kis, Gregor Serša, 2021, izvirni znanstveni članek Ključne besede: electrochemotherapy, electroporation, bleomycin, pharmacokinetics, blood samples, tumor samples, drug delivery Celotno besedilo (datoteka, 665,51 KB) Gradivo ima več datotek! Več... |
42. The potential of macroporous silica—nanocrystalline cellulose combination for formulating dry emulsion systems with improved flow propertiesMitja Pohlen, Luka Pirker, Rok Dreu, 2021, izvirni znanstveni članek Ključne besede: simvastatin, dry emulsion, lipid-based drug delivery systems, nanocrystalline cellulose, macroporous silica, spray drying, flowability, DoE Celotno besedilo (datoteka, 8,73 MB) Gradivo ima več datotek! Več... |
|
44. Targeting autophagy triggers apoptosis and complements the action of venetoclax in chronic lymphocytic leukemia cellsDamjan Avsec, Alma Tana Jakoš Djordjevič, Maša Kandušer, Helena Podgornik, Matevž Škerget, Irena Mlinarič-Raščan, 2021, izvirni znanstveni članek Ključne besede: chronic lymphocytic leukemia, autophagy, AMPK/ULK1, venetoclax, drug resistance, targeted therapy Celotno besedilo (datoteka, 5,50 MB) Gradivo ima več datotek! Več... |
45. In vitro ciliotoxicity and cytotoxicity testing of repeated chronic exposure to topical nasal formulations for safety studiesLarisa Tratnjek, Nadica Sibinovska, Katja Kristan, Mateja Erdani-Kreft, 2021, izvirni znanstveni članek Ključne besede: nasal drug formulations, mucociliary clearance, cytotoxicity, ciliary beat frequency, nasal in vitro model, repeated exposure, ciliotoxicity, ultrastructural analysis, drug safety Celotno besedilo (datoteka, 6,01 MB) Gradivo ima več datotek! Več... |
46. Polymorphism in gene for ABCC2 transporter predicts methotrexate drug survival in patients with psoriasisJasna Grželj, Maruška Marovt, Pij B. Marko, Irena Mlinarič-Raščan, Tanja Gmeiner, Alenka Šmid, 2021, izvirni znanstveni članek Ključne besede: psoriasis, drug survival, methotrexate, pharmacogenetics Celotno besedilo (datoteka, 865,71 KB) Gradivo ima več datotek! Več... |
47. Ustekinumab dosing individualization in Crohn's disease guided by a population pharmacokinetic-pharmacodynamic modelJurij Zdovc, Jurij Hanžel, Borut Štabuc, Tomaž Vovk, Barbara Ostanek, David Drobne, Iztok Grabnar, 2021, izvirni znanstveni članek Ključne besede: ustekinumab, inflammatory bowel disease, fecal calprotectin, pharmacokinetics-pharmacodynamics, therapeutic drug monitoring Celotno besedilo (datoteka, 1,20 MB) Gradivo ima več datotek! Več... |
48. COVID-19 vaccines safety tracking (CoVaST)Abanoub Riad, Janja Marc, Miloslav Klugar, 2021, izvirni znanstveni članek Ključne besede: cohort studies, cross-sectional studies, COVID-19, drug-related side effects, adverse reactions, health personnel, mass vaccination, prevalence Celotno besedilo (datoteka, 560,94 KB) Gradivo ima več datotek! Več... |
49. Predicting drug release rate of implantable matrices and better understanding of the underlying mechanisms through experimental design and artificial neural network-based modellingErnő Benkő, Ilija German Ilić, Katalin Kristó, Géza Regdon, Ildikó Csóka, Klára Pintye-Hódi, Stanko Srčič, Tamás Sovány, 2022, izvirni znanstveni članek Ključne besede: drug–excipient interaction, polymers, non-degradable polymers, matrix tablet, controlled release, design of experiments, artificial neural networks Celotno besedilo (datoteka, 3,15 MB) Gradivo ima več datotek! Več... |
50. Epstein-Barr virus-encoded BILF1 orthologues from porcine lymphotropic herpesviruses display common molecular functionalityMaša Mavri, Valentina Kubale, Daniel P. Depledge, Jianmin Zuo, Christene A. Huang, Judith Breuer, Milka Vrecl, Michael A. Jarvis, Eva Jarc Jovičić, Toni Petan, Bernhard Ehlers, Mette Marie Rosenkilde, Katja Spiess, 2022, izvirni znanstveni članek Ključne besede: Epstein-Barr virus, porcine lymphotropic herpesviruses (PLHV), BILF1, G protein signaling, MHC class I, drug target, post-transplant lymphoproliferative disease, in-vivo model Celotno besedilo (datoteka, 6,64 MB) Gradivo ima več datotek! Več... |